• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.新冠病毒疫苗对实体器官和胰岛移植受者中因感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔变异株导致的住院和死亡的有效性。
Transplantation. 2022 Jun 1;106(6):e310-e311. doi: 10.1097/TP.0000000000004104. Epub 2022 Mar 8.
2
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis.两剂严重急性呼吸综合征冠状病毒2型疫苗降低实体器官移植受者因新冠肺炎死亡的风险：英国登记处关联分析的初步结果
Transplantation. 2021 Nov 1;105(11):e263-e264. doi: 10.1097/TP.0000000000003908.
3
Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.实体器官移植受者额外接种一剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的临床效果。
Clin Transplant. 2022 Mar;36(3):e14601. doi: 10.1111/ctr.14601. Epub 2022 Jan 28.
4
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.评估 4 剂 SARS-CoV-2 信使 RNA 疫苗在实体器官移植受者中的效果。
JAMA Netw Open. 2021 Nov 1;4(11):e2136030. doi: 10.1001/jamanetworkopen.2021.36030.
5
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.实体器官移植受者中首剂严重急性呼吸综合征冠状病毒2疫苗接种的安全性
Transplantation. 2021 May 1;105(5):e56-e57. doi: 10.1097/TP.0000000000003654.
6
Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。
Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.
7
Solid-Organ Transplant Recipient Attitudes Regarding COVID-19 and the COVID-19 Vaccines.实体器官移植受者对2019冠状病毒病及2019冠状病毒病疫苗的态度
Exp Clin Transplant. 2023 Jun;21(6):543-544. doi: 10.6002/ect.2022.0246. Epub 2023 Jan 16.
8
Update on COVID-19 vaccination in pediatric solid organ transplant recipients.儿童实体器官移植受者 COVID-19 疫苗接种的最新进展。
Pediatr Transplant. 2022 Aug;26(5):e14235. doi: 10.1111/petr.14235. Epub 2022 Jan 20.
9
Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.疫苗对英国实体器官和胰岛移植受者中 SARS-CoV-2 B.1.1.529 奥密克戎变异株的有效性：一项全国性回顾性队列研究。
Transplantation. 2023 May 1;107(5):1124-1135. doi: 10.1097/TP.0000000000004535. Epub 2023 Jan 25.
10
Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.COVID-19 疫苗在实体器官移植受者中的首剂、二剂和三剂的有效性：来自加拿大的一项基于人群的队列研究。
Am J Transplant. 2022 Sep;22(9):2228-2236. doi: 10.1111/ajt.17095. Epub 2022 Jun 1.

引用本文的文献

1
How do large-scale population studies inform vaccine evaluations in England?大规模人口研究如何为英国的疫苗评估提供信息？
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf006.
2
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial.重复接种新冠疫苗可激发肾移植受者的记忆性T细胞和B细胞反应：一项多中心随机对照试验的结果
Transplantation. 2024 Dec 1;108(12):2420-2433. doi: 10.1097/TP.0000000000005119. Epub 2024 Nov 21.
3
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB.第三剂 BNT162b2 可提高肝移植受者对原始株的免疫应答，但对奥密克戎 BA.1 和 XBB 无效。
Front Immunol. 2023 Jul 3;14:1206016. doi: 10.3389/fimmu.2023.1206016. eCollection 2023.
4
Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation.移植后早期接种 SARS-CoV-2 加强疫苗时，移植前预先致敏的患者缺乏血清学反应。
Front Immunol. 2023 Jan 16;13:1083167. doi: 10.3389/fimmu.2022.1083167. eCollection 2022.
5
Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant recipients.肾移植受者在第二次接种疫苗后较长间隔时间接种第三剂 SARS-CoV-2 mRNA 疫苗的体液和细胞免疫应答及安全性。
Front Immunol. 2022 Nov 30;13:1050211. doi: 10.3389/fimmu.2022.1050211. eCollection 2022.
6
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients.肾移植受者接种第三剂和第四剂异源和同源新冠疫苗后的免疫反应。
EClinicalMedicine. 2022 Nov;53:101642. doi: 10.1016/j.eclinm.2022.101642. Epub 2022 Sep 9.

Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.

作者信息

Williams Sarah V, Whitaker Heather J, Mumford Lisa, Callaghan Chris, Curtis Rebecca M K, Stowe Julia, Kirsebom Freja, Thomas James, Ushiro-Lumb Ines, Ravanan Rommel, Lopez-Bernal Jamie

机构信息

UK Health Security Agency, London, United Kingdom.

National Health Service Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.

出版信息

Transplantation. 2022 Jun 1;106(6):e310-e311. doi: 10.1097/TP.0000000000004104. Epub 2022 Mar 8.

DOI:10.1097/TP.0000000000004104
PMID:35283455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9128400/
Abstract
摘要